Axonics is a medical technology company known for implantable sacral neuromodulation systems used to treat bladder and bowel disorders. The organization employs roughly 520 people and has added new roles while navigating some turnover, resulting in a net workforce slightly above the five-hundred mark. Hiring has been measured compared with total attrition, indicating a focus on selective expansion rather than rapid scaling. The headcount data suggests Axonics prioritizes specialized clinical expertise and customer-facing support to bring its therapies to market.
Sales and Support is the largest group, accounting for about one-third of all employees with 183 team members dedicated to commercial outreach, training, and field assistance. Healthcare specialists—including clinical affairs and medical professionals—form the next-largest segment at 168 employees, highlighting the company’s need for deep therapeutic knowledge. Core product innovation is driven by a 32-person Engineering team, complemented by 28 people in Marketing and Product who guide go-to-market strategy. Operations, Finance & Administration, and Human Resources collectively total just over 60 employees, providing the infrastructure required to scale, while 45 staff are classified in Other roles, reflecting a diverse range of support functions.
Axonics’ workforce is widely distributed, with 387 employees listed under "Other" locations that include remote and field-based roles. The corporate headquarters in Irvine, California hosts 45 employees, serving as the primary hub for engineering, quality, and leadership functions. Additional concentrations appear across Southern California—15 employees in Orange County and 15 in Los Angeles—along with smaller pockets in New York, St. Louis, Santa Ana, Nashville, and Tampa, each housing fewer than ten employees. This geographic spread underscores the field-oriented nature of medical-device commercialization, ensuring clinical and sales support is available near key markets and healthcare providers.